Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
doi: 10.1111/dom.15058 46 YamadaYKatagiriHHamamotoYDeenadayalanSNavarriaANishijimaKet al
The review contextualised native GLP-1 as the reference molecule for the entire dual GIP/GLP-1 receptor agonist research field including tirzepatide (approved) and novel triple agonists targeting GLP-1R, GIPR, and GCGR simultaneously confirming native GLP-1s ongoing research importance as the pharmacological anchor of this rapidly expanding compound class
HK was responsible for conception and design of the present study
Patients receiving combination therapy showed greater weight reduction compared to either agent alone
Activation of these receptors may enhance respiratory stability during sleep independent of body weight changes
10.1093/sleep/30.11.1445 107
US$ 24.22
US$ 28.68
US$ 27.66
US$ 28.12
US$ 29.62
